Recital 27, Regulation (EU) 2025/2316

In forcesince 17 Nov 2025

It is therefore likely for all of the active substances covered by this Regulation that no decision on the renewal of the approval can be taken before the expiry of their respective approval periods, between 15 January and 31 March 2026. Furthermore, the reasons for the delays in these renewal procedures are beyond the control of the respective applicants. Therefore, the approval periods of those active substances should be extended to enable the completion of the assessments required and to finalise the respective procedures on the renewal of the approvals.